Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis
Recent findings highlight the emerging role of the endocannabinoid system in the control of symptoms and disease progression in multiple sclerosis (MS). MS is a chronic, immune-mediated, demyelinating disorder of the central nervous system with no cure so far. It is widely reported in the literature...
Main Authors: | Francesca Gado, Maria Digiacomo, Marco Macchia, Simone Bertini, Clementina Manera |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | Medicines |
Subjects: | |
Online Access: | http://www.mdpi.com/2305-6320/5/3/91 |
Similar Items
-
Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization
by: Maddalena Grieco, et al.
Published: (2021-07-01) -
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
by: Robert Ramer, et al.
Published: (2019-05-01) -
Discovery of Uracil Derivatives as Potent Inhibitors of Fatty Acid Amide Hydrolase
by: Yan Qiu, et al.
Published: (2016-02-01) -
Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
by: Baswan SM, et al.
Published: (2020-12-01) -
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
by: Carlotta Granchi, et al.
Published: (2017-01-01)